MAX Mutations in Endometrial Cancer: Clinicopathologic Associations and Recurrent MAX p.His28Arg Functional Characterization.

MLA

Walker, Christopher J., et al. “MAX Mutations in Endometrial Cancer: Clinicopathologic Associations and Recurrent MAX p.His28Arg Functional Characterization.” Journal of the National Cancer Institute, vol. 110, no. 5, May 2018, pp. 517–26. EBSCOhost, https://doi.org/10.1093/jnci/djx238.

APA

Walker, C. J., Rush, C. M., Dama, P., O’Hern, M. J., Cosgrove, C. M., Gillespie, J. L., Zingarelli, R. A., Smith, B., Stein, M. E., Mutch, D. G., Shakya, R., Chang, C.-W., Selvendiran, K., Song, J. W., Cohn, D. E., & Goodfellow, P. J. (2018). MAX Mutations in Endometrial Cancer: Clinicopathologic Associations and Recurrent MAX p.His28Arg Functional Characterization. Journal of the National Cancer Institute, 110(5), 517–526. https://doi.org/10.1093/jnci/djx238

Chicago

Walker, Christopher J, Craig M Rush, Paola Dama, Matthew J O’Hern, Casey M Cosgrove, Jessica L Gillespie, Roman A Zingarelli, et al. 2018. “MAX Mutations in Endometrial Cancer: Clinicopathologic Associations and Recurrent MAX p.His28Arg Functional Characterization.” Journal of the National Cancer Institute 110 (5): 517–26. doi:10.1093/jnci/djx238.